Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rozenbaum

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Seminars in Arthritis and Rheumatism|January 16, 2003
Hemodynamics instability score in chronic fatigue syndrome and in non-chronic fatigue syndromeJochanan E Naschitz, Edmond Sabo, Shaul Naschitz, et al.
The Journal of Rheumatology|February 5, 2005
Cardiovascular reactivity in fibromyalgia: evidence for pathogenic heterogeneityJochanan E Naschitz, Michael Rozenbaum, Madeline C Fields, et al.
Clinical and Experimental Rheumatology|November 18, 2017
A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controlsMerav Lidar, Yael Brantz, Yael Shinar, et al.
Rheumatology (Oxford, England)|September 6, 2023
Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapyShiri Keret, Israel Henig, Tsila Zuckerman, et al.
Rheumatology (Oxford, England)|November 1, 2024
Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosisShiri Keret, Lisa Kaly, George Schett, et al.
Rheumatology (Oxford, England)|February 17, 2019
Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre studyZahava Vadasz, Alexandra Balbir Gurman, Pierluigi Meroni, et al.
The Journal of Rheumatology|December 1, 2007
Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trialMichael H Silverman, Vibeke Strand, Doron Markovits, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Seminars in Arthritis and Rheumatism|January 16, 2003
Hemodynamics instability score in chronic fatigue syndrome and in non-chronic fatigue syndromeJochanan E Naschitz, Edmond Sabo, Shaul Naschitz, et al.
The Journal of Rheumatology|February 5, 2005
Cardiovascular reactivity in fibromyalgia: evidence for pathogenic heterogeneityJochanan E Naschitz, Michael Rozenbaum, Madeline C Fields, et al.
Clinical and Experimental Rheumatology|November 18, 2017
A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controlsMerav Lidar, Yael Brantz, Yael Shinar, et al.
Rheumatology (Oxford, England)|September 6, 2023
Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapyShiri Keret, Israel Henig, Tsila Zuckerman, et al.
Rheumatology (Oxford, England)|November 1, 2024
Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosisShiri Keret, Lisa Kaly, George Schett, et al.
Rheumatology (Oxford, England)|February 17, 2019
Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre studyZahava Vadasz, Alexandra Balbir Gurman, Pierluigi Meroni, et al.
The Journal of Rheumatology|December 1, 2007
Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trialMichael H Silverman, Vibeke Strand, Doron Markovits, et al.
Pageof 10